pyridostigmine bromide has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casassus-Buihle, D; Chauveau, E; Fraudin, A; Oddes, B; Reffet, A; Terrier, F | 1 |
| Eddy, S; Jan, T; Peter, VE; Tanja, R; Werner, VS; Wim, R | 1 |
2 other study(ies) available for pyridostigmine bromide and Chronic Hepatitis C
| Article | Year |
|---|---|
[Development of a myasthenia crisis during interferon treatment for chronic C hepatitis].
Topics: Aged; Antiviral Agents; Cholinesterase Inhibitors; Follow-Up Studies; Glucocorticoids; Hepatitis C, Chronic; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Male; Myasthenia Gravis; Mycophenolic Acid; Prednisone; Pyridostigmine Bromide; Ribavirin | 2007 |
Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection.
Topics: Autoantibodies; Cholinesterase Inhibitors; Hepatitis C, Chronic; Humans; Male; Middle Aged; Muscle, Skeletal; Myasthenia Gravis; Pyridostigmine Bromide; Receptors, Cholinergic | 1999 |